Evidence map›Paper›PMID 30144001›Full record

ArticleInternational journal of hematology2018

Three cases of spontaneous splenic rupture in malignant lymphoma.

Jun Amaki, Tatsuya Sekiguchi, Shinichiro Hiraiwa, Hiroshi Kajiwara, Hidetsugu Kawai, Akifumi Ichiki, Naoya Nakamura, Kiyoshi Ando

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in International journal of hematology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Jun AmakiDivision of Hematology/Oncology, Department of Internal Medicine, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, 259-1143, Japan. junamaki@tokai-u.jp.ORCID http://orcid.org/0000-0003-4911-2516
Tatsuya SekiguchiDepartment of Radiology, Tokai University School of Medicine, Isehara, Japan.
Shinichiro HiraiwaDepartment of Pathology, Tokai University School of Medicine, Isehara, Japan.
Hiroshi KajiwaraDepartment of Pathology, Tokai University School of Medicine, Isehara, Japan.
Hidetsugu KawaiDivision of Hematology/Oncology, Department of Internal Medicine, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, 259-1143, Japan.
Akifumi IchikiDivision of Hematology/Oncology, Department of Internal Medicine, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, 259-1143, Japan.
Naoya NakamuraDepartment of Pathology, Tokai University School of Medicine, Isehara, Japan.
Kiyoshi AndoDivision of Hematology/Oncology, Department of Internal Medicine, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, 259-1143, Japan.
Tokai University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Spontaneous splenic rupture is a rare but often life-threatening condition. However, there is no consensus on appropriate management for this condition, due to its rarity. Here, we report three cases of malignant lymphoma with spontaneous splenic rupture. In each case, progression of splenic bleeding was rapid and complicated by malignant lymphoma. Spontaneous splenic rupture complicated by malignant lymphoma may cause exacerbation of anemia and hypovolemic shock. When splenic rupture is indicated by abdominal pain, tachycardia, or hypotension in a patient with splenomegaly, abdominal examination should be performed immediately, and emergency transcatheter arterial embolization and/or splenectomy should be considered.

Indexed as

AgedAntibodies, Monoclonal, Murine-DerivedAntineoplastic Combined Chemotherapy ProtocolsBiomarkersBiopsyBlood CoagulationBone MarrowCyclophosphamideDoxorubicinEmbolization, TherapeuticHumansLymphomaMaleMiddle AgedPrednisoneRituximabAntibodies, Monoclonal, Murine-DerivedBiomarkersCyclophosphamideDoxorubicinPrednisoneR-CHOP protocolRituximabVincristineMalignant lymphomaSplenomegalySpontaneous splenic ruptureTranscatheter arterial embolization

Identifiers

PMID30144001
OpenAlexW2888361733

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.